Confirmation that community pharmacies are expected to begin receiving supplies of the Moderna COVID-19 vaccine from next week has been welcomed by the Guild
NSW Branch Director of the Pharmacy Guild Caroline Argent said the arrival of the vaccine in pharmacies would give Australians across the country greater access to protection against COVID-19.
“The Moderna vaccine has been approved for people aged 12 and above and so its availability greatly broadens the range of people who can be vaccinated,” Ms Argent said.
“With the arrival of the Moderna vaccine all adolescents and adults can be covered.
“Increasingly we are seeing evidence of younger people being affected by the Delta strain of COVID-19, so it is imperative that this age group is protected along with the rest of the community throughout NSW.
“Eligible community pharmacies will be administering the Moderna vaccine as soon as the staged supplies are delivered.
“Importantly the availability of the Moderna vaccine means there are now two mRNA vaccines available in Australia – Moderna and Pfizer.”
David Heffernan, NSW Branch President, said that the Moderna vaccine had similar efficacy and safety profiles to the Pfizer vaccine.
“Significantly for patients in NSW, the accessibility of their local community pharmacies means they have plenty of opportunities to get their vaccine when it is convenient for them,” he said, highlighting the channel’s longer opening hours.
“Pharmacies have helped get the vaccine rollout back on track and will now be able to further consolidate that rollout with the Moderna vaccine.”
Last week the Therapeutic Goods Administration announced that it had provisionally approved the use of the Moderna Australia Pty Ltd COVID-19 vaccine SPIKEVAX (elasomeran) in individuals 12 years and older.
This decision followed the August provisional approval it granted to Spikevax for use in individuals aged 18 years and older.